South Africa rolls out Africa’s first trials for COVID-19 vaccine

South Africa rolls out continent's first trials for COVID-19 vaccine -  World - The Jakarta Post

Oxford University rolled out Africa’s first human trials for a potential vaccine against the new coronavirus in South Africa on Wednesday, as cases continue to rise and concerns grow over potential access to life-saving treatments.

The trial, conducted with local partner the University of the Witwatersrand, will consist of 2,000 volunteers from 18 to 65 years of age, including some HIV positive patients, who will be monitored for 12 months after vaccination to assess how well the vaccine guards against COVID-19.

“Once 60% of the population, especially the adult population, becomes immune, we expect that effective reproductive rate to go under 1, which basically means the virus will still be around, it will still circulate, but its chain of transmission has been interrupted,” said Shabir Madhi, professor of vaccinology at Wits University and leader of the trial.

Hopes are that South Africa’s involvement in vaccine trials will ensure the continent will have access to an affordable vaccine and not be left at the back of the queue.

source: citinewsroom

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s